1. Ku JH. The management of neurogenic bladder and quality of life in spinal cord injury. BJU Int 2006;98:739-745. PMID:
16978269.
2. Bauer SB. Neurogenic bladder: etiology and assessment. Pediatr Nephrol 2008;23:541-551. PMID:
18270749.
3. Chancellor MB, Anderson RU, Boone TB. Pharmacotherapy for neurogenic detrusor overactivity. Am J Phys Med Rehabil 2006;85:536-545. PMID:
16715024.
4. Selzman AA, Elder JS, Mapstone TB. Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord. Urol Clin North Am 1993;20:485-504. PMID:
8351774.
5. Reyblat P, Ginsberg DA. Augmentation cystoplasty: what are the indications? Curr Urol Rep 2008;9:452-458. PMID:
18947509.
6. Jeong SJ, Cho SY, Oh SJ. Spinal cord/brain injury and the neurogenic bladder. Urol Clin North Am 2010;37:537-546. PMID:
20955905.
7. Panicker JN, de Sèze M, Fowler CJ. Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management. Clin Rehabil 2010;24:579-589. PMID:
20584864.
8. Bauer SB, Hallett M, Khoshbin S, Lebowitz RL, Winston KR, Gibson S, et al. Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 1984;252:650-652. PMID:
6737668.
9. Wu HY, Baskin LS, Kogan BA. Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol 1997;157:2295-2297. PMID:
9146656.
10. Scales CD Jr, Wiener JS. Evaluating outcomes of enterocystoplasty in patients with spina bifida: a review of the literature. J Urol 2008;180:2323-2329. PMID:
18930285.
11. McDougal WS. Metabolic complications of urinary intestinal diversion. J Urol 1992;147:1199-1208. PMID:
1569649.
12. Cartwright PC, Snow BW. Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel. J Urol 1989;142:1050-1053. PMID:
2795729.
13. Cartwright PC, Snow BW. Bladder autoaugmentation: early clinical experience. J Urol 1989;142(2 Pt 2):505-508. PMID:
2746767.
14. Bellinger MF. Ureterocystoplasty: a unique method for vesical augmentation in children. J Urol 1993;149:811-813. PMID:
8455246.
15. Churchill BM, Aliabadi H, Landau EH, McLorie GA, Steckler RE, McKenna PH, et al. Ureteral bladder augmentation. J Urol 1993;150(2 Pt 2):716-720. PMID:
8326632.
16. Adams MC, Brock JW 3rd, Pope JC 4th, Rink RC. Ureterocystoplasty: is it necessary to detubularize the distal ureter? J Urol 1998;160(3 Pt 1):851-853. PMID:
9720574.
17. Hasetine W. A brave new medicine A conversation with William Haseltine Interview by Joe Flower. Health Forum J 1999;42:28-30. 61-65. PMID:
10539016.
18. Chun SY, Lim GJ, Kwon TG, Kwak EK, Kim BW, Atala A, et al. Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials 2007;28:4251-4256. PMID:
17617449.
19. Sharon JL, Puleo DA. The use of N-terminal immobilization of PTH(1-34) on PLGA to enhance bioactivity. Biomaterials 2008;29:3137-3142. PMID:
18448162.
20. Kim BS, Baez CE, Atala A. Biomaterials for tissue engineering. World J Urol 2000;18:2-9. PMID:
10766037.
21. Tabata Y. Current status of regenerative medical therapy based on drug delivery technology. Reprod Biomed Online 2008;16:70-80. PMID:
18252050.
22. Atala A, Peters CA, Retik AB, Mandell J. Endoscopic treatment of vesicoureteral reflux with a self-detachable balloon system. J Urol 1992;148(2 Pt 2):724-727. PMID:
1640555.
23. Riehmann M, Gasser TC, Bruskewitz RC. The Hydroflex penile prosthesis: a test case for the introduction of new urological technology. J Urol 1993;149(5 Pt 2):1304-1307. PMID:
8479021.
24. Levesque PE, Bauer SB, Atala A, Zurakowski D, Colodny A, Peters C, et al. Ten-year experience with the artificial urinary sphincter in children. J Urol 1996;156(2 Pt 2):625-628. PMID:
8683746.
25. Ikada Y. Challenges in tissue engineering. J R Soc Interface 2006;3:589-601. PMID:
16971328.
26. Atala A, Vacanti JP, Peters CA, Mandell J, Retik AB, Freeman MR. Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol 1992;148(2 Pt 2):658-662. PMID:
1322466.
27. Atala A, Cima LG, Kim W, Paige KT, Vacanti JP, Retik AB, et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol 1993;150(2 Pt 2):745-747. PMID:
8326638.
28. Atala A, Freeman MR, Vacanti JP, Shepard J, Retik AB. Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J Urol 1993;150(2 Pt 2):608-612. PMID:
8326605.
29. Atala A, Kim W, Paige KT, Vacanti CA, Retik AB. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J Urol 1994;152(2 Pt 2):641-643. PMID:
8021988.
30. Atala A. Tissue engineering, stem cells, and cloning for the regeneration of urologic organs. Clin Plast Surg 2003;30:649-667. PMID:
14621312.
31. Atala A. Recent applications of regenerative medicine to urologic structures and related tissues. Curr Opin Urol 2006;16:305-309. PMID:
16770133.
32. Atala A, Guzman L, Retik AB. A novel inert collagen matrix for hypospadias repair. J Urol 1999;162(3 Pt 2):1148-1151. PMID:
10458452.
33. Atala A. Autologous cell transplantation for urologic reconstruction. J Urol 1998;159:2-3. PMID:
9400425.
34. Cilento BG, Freeman MR, Schneck FX, Retik AB, Atala A. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol 1994;152(2 Pt 2):665-670. PMID:
7517459.
35. Yoo JJ, Atala A. A novel gene delivery system using urothelial tissue engineered neo-organs. J Urol 1997;158(3 Pt 2):1066-1070. PMID:
9258143.
36. Fauza DO, Fishman SJ, Mehegan K, Atala A. Videofetoscopically assisted fetal tissue engineering: skin replacement. J Pediatr Surg 1998;33:357-361. PMID:
9498417.
37. Fauza DO, Fishman SJ, Mehegan K, Atala A. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Pediatr Surg 1998;33:7-12. PMID:
9473089.
38. Yoo JJ, Meng J, Oberpenning F, Atala A. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 1998;51:221-225. PMID:
9495701.
39. Amiel GE, Atala A. Current and future modalities for functional renal replacement. Urol Clin North Am 1999;26:235-246. xi. PMID:
10086063.
40. Kershen RT, Atala A. New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin North Am 1999;26:81-94. viii. PMID:
10086052.
41. Oberpenning F, Meng J, Yoo JJ, Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 1999;17:149-155. PMID:
10052350.
42. Park HJ, Yoo JJ, Kershen RT, Moreland R, Atala A. Reconstitution of human corporal smooth muscle and endothelial cells in vivo. J Urol 1999;162(3 Pt 2):1106-1109. PMID:
10458441.
43. Scriven SD, Booth C, Thomas DF, Trejdosiewicz LK, Southgate J. Reconstitution of human urothelium from monolayer cultures. J Urol 1997;158(3 Pt 2):1147-1152. PMID:
9258159.
44. Liebert M, Hubbel A, Chung M, Wedemeyer G, Lomax MI, Hegeman A, et al. Expression of mal is associated with urothelial differentiation in vitro: identification by differential display reverse-transcriptase polymerase chain reaction. Differentiation 1997;61:177-185. PMID:
9084136.
45. Puthenveettil JA, Burger MS, Reznikoff CA. Replicative senescence in human uroepithelial cells. Adv Exp Med Biol 1999;462:83-91. PMID:
10599415.
46. Liebert M, Wedemeyer G, Abruzzo LV, Kunkel SL, Hammerberg C, Cooper KD, et al. Stimulated urothelial cells produce cytokines and express an activated cell surface antigenic phenotype. Semin Urol 1991;9:124-130. PMID:
1853009.
47. Harriss DR. Smooth muscle cell culture: a new approach to the study of human detrusor physiology and pathophysiology. Br J Urol 1995;75(Suppl 1):18-26. PMID:
7613854.
48. Freeman MR, Yoo JJ, Raab G, Soker S, Adam RM, Schneck FX, et al. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 1997;99:1028-1036. PMID:
9062361.
49. Solomon LZ, Jennings AM, Sharpe P, Cooper AJ, Malone PS. Effects of short-chain fatty acids on primary urothelial cells in culture: implications for intravesical use in enterocystoplasties. J Lab Clin Med 1998;132:279-283. PMID:
9794698.
50. Lobban ED, Smith BA, Hall GD, Harnden P, Roberts P, Selby PJ, et al. Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol 1998;153:1957-1967. PMID:
9846985.
51. Nguyen HT, Park JM, Peters CA, Adam RM, Orsola A, Atala A, et al. Cell-specific activation of the HB-EGF and ErbB1 genes by stretch in primary human bladder cells. In Vitro Cell Dev Biol Anim 1999;35:371-375. PMID:
10462199.
52. Rackley RR, Bandyopadhyay SK, Fazeli-Matin S, Shin MS, Appell R. Immunoregulatory potential of urothelium: characterization of NF-kappaB signal transduction. J Urol 1999;162:1812-1816. PMID:
10524940.
53. Lin HK, Cowan R, Moore P, Zhang Y, Yang Q, Peterson JA Jr, et al. Characterization of neuropathic bladder smooth muscle cells in culture. J Urol 2004;171:1348-1352. PMID:
14767346.
54. Lai JY, Yoon CY, Yoo JJ, Wulf T, Atala A. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol 2002;168(4 Pt 2):1853-1857. PMID:
12352375.
55. Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J. Stem cells. Setting standards for human embryonic stem cells. Science 2003;300:913-916. PMID:
12738841.
56. Devine SM. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl 2002;38:73-79. PMID:
12046853.
57. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49. PMID:
12077603.
58. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341-347. PMID:
17620285.
59. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008;26:2287-2299. PMID:
18566331.
60. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25:100-106. PMID:
17206138.
61. Hochedlinger K, Rideout WM, Kyba M, Daley GQ, Blelloch R, Jaenisch R. Nuclear transplantation, embryonic stem cells and the potential for cell therapy. Hematol J 2004;5(Suppl 3):S114-S117. PMID:
15190291.
62. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. PMID:
16904174.
63. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872. PMID:
18035408.
64. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920. PMID:
18029452.
65. Apodaca G. The uroepithelium: not just a passive barrier. Traffic 2004;5:117-128. PMID:
15086788.
66. Negrete HO, Lavelle JP, Berg J, Lewis SA, Zeidel ML. Permeability properties of the intact mammalian bladder epithelium. Am J Physiol 1996;271:F886-F894. PMID:
8898019.
67. Kaefer M, Hendren WH, Bauer SB, Goldenblatt P, Peters CA, Atala A, et al. Reservoir calculi: a comparison of reservoirs constructed from stomach and other enteric segments. J Urol 1998;160(6 Pt 1):2187-2190. PMID:
9817364.
68. Kaefer M, Tobin MS, Hendren WH, Bauer SB, Peters CA, Atala A, et al. Continent urinary diversion: the Children's Hospital experience. J Urol 1997;157:1394-1399. PMID:
9120962.
69. Atala A. Commentary on the replacement of urologic associated mucosa. J Urol 1996;156:338-339. PMID:
8683675.
70. Probst M, Dahiya R, Carrier S, Tanagho EA. Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 1997;79:505-515. PMID:
9126077.
71. Sutherland RS, Baskin LS, Hayward SW, Cunha GR. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol 1996;156(2 Pt 2):571-577. PMID:
8683736.
72. Piechota HJ, Dahms SE, Nunes LS, Dahiya R, Lue TF, Tanagho EA. In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft. J Urol 1998;159:1717-1724. PMID:
9554400.
73. Wefer J, Sievert KD, Schlote N, Wefer AE, Nunes L, Dahiya R, et al. Time dependent smooth muscle regeneration and maturation in a bladder acellular matrix graft: histological studies and in vivo functional evaluation. J Urol 2001;165:1755-1759. PMID:
11342970.
74. Kikuno N, Kawamoto K, Hirata H, Vejdani K, Kawakami K, Fandel T, et al. Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder. BJU Int 2009;103:1424-1428. PMID:
18990142.
75. Badylak SF, Lantz GC, Coffey A, Geddes LA. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 1989;47:74-80. PMID:
2739401.
76. Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002;13:377-383. PMID:
12324220.
77. Kropp BP, Rippy MK, Badylak SF, Adams MC, Keating MA, Rink RC, et al. Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long-term canine bladder augmentations. J Urol 1996;155:2098-2104. PMID:
8618344.
78. Kropp BP, Sawyer BD, Shannon HE, Rippy MK, Badylak SF, Adams MC, et al. Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility. J Urol 1996;156(2 Pt 2):599-607. PMID:
8683741.
79. Vaught JD, Kropp BP, Sawyer BD, Rippy MK, Badylak SF, Shannon HE, et al. Detrusor regeneration in the rat using porcine small intestinal submucosal grafts: functional innervation and receptor expression. J Urol 1996;155:374-378. PMID:
7490890.
80. Portis AJ, Elbahnasy AM, Shalhav AL, Brewer A, Humphrey P, McDougall EM, et al. Laparoscopic augmentation cystoplasty with different biodegradable grafts in an animal model. J Urol 2000;164:1405-1411. PMID:
10992423.
81. Landman J, Olweny E, Sundaram CP, Andreoni C, Collyer WC, Rehman J, et al. Laparoscopic mid sagittal hemicystectomy and bladder reconstruction with small intestinal submucosa and reimplantation of ureter into small intestinal submucosa: 1-year followup. J Urol 2004;171(6 Pt 1):2450-2455. PMID:
15126874.
82. Kropp BP, Cheng EY, Lin HK, Zhang Y. Reliable and reproducible bladder regeneration using unseeded distal small intestinal submucosa. J Urol 2004;172(4 Pt 2):1710-1713. PMID:
15371796.
83. Jayo MJ, Jain D, Wagner BJ, Bertram TA. Early cellular and stromal responses in regeneration versus repair of a mammalian bladder using autologous cell and biodegradable scaffold technologies. J Urol 2008;180:392-397. PMID:
18499157.
84. Zhang Y. Bladder reconstruction by tissue engineering--with or without cells? J Urol 2008;180:10-11. PMID:
18485386.
85. Nguyen MM, Lieu DK, deGraffenried LA, Isseroff RR, Kurzrock EA. Urothelial progenitor cells: regional differences in the rat bladder. Cell Prolif 2007;40:157-165. PMID:
17472724.
86. Kurzrock EA, Lieu DK, Degraffenried LA, Chan CW, Isseroff RR. Label-retaining cells of the bladder: candidate urothelial stem cells. Am J Physiol Renal Physiol 2008;294:F1415-F1421. PMID:
18367656.
87. Shukla D, Box GN, Edwards RA, Tyson DR. Bone marrow stem cells for urologic tissue engineering. World J Urol 2008;26:341-349. PMID:
18654786.
88. Anumanthan G, Makari JH, Honea L, Thomas JC, Wills ML, Bhowmick NA, et al. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol 2008;180(4 Suppl):1778-1783. PMID:
18721942.
89. Oottamasathien S, Wang Y, Williams K, Franco OE, Wills ML, Thomas JC, et al. Directed differentiation of embryonic stem cells into bladder tissue. Dev Biol 2007;304:556-566. PMID:
17289017.
90. Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, et al. Urine derived cells are a potential source for urological tissue reconstruction. J Urol 2008;180:2226-2233. PMID:
18804817.
91. Wu S, Liu Y, Bharadwaj S, Atala A, Zhang Y. Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials 2011;32:1317-1326. PMID:
21055807.
92. de Boer WI, Schuller AG, Vermey M, van der Kwast TH. Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol 1994;145:1199-1207. PMID:
7977650.
93. Jayo MJ, Jain D, Ludlow JW, Payne R, Wagner BJ, McLorie G, et al. Long-term durability, tissue regeneration and neo-organ growth during skeletal maturation with a neo-bladder augmentation construct. Regen Med 2008;3:671-682. PMID:
18729792.
94. Kwon TG, Yoo JJ, Atala A. Local and systemic effects of a tissue engineered neobladder in a canine cystoplasty model. J Urol 2008;179:2035-2041. PMID:
18355869.
95. Zhang Y, Frimberger D, Cheng EY, Lin HK, Kropp BP. Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model. BJU Int 2006;98:1100-1105. PMID:
17034611.
96. Farhat WA, Yeger H. Does mechanical stimulation have any role in urinary bladder tissue engineering? World J Urol 2008;26:301-305. PMID:
18690457.
97. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006;367:1241-1246. PMID:
16631879.